High hopes for new malaria vaccine based on blood protein


Science Editor

A new type of malaria vaccine based on proteins found in the blood of children who develop a natural resistance to the parasitic disease has been developed by American researchers.

Tests on laboratory mice have shown that the vaccine can protect the animals against the most lethal strains of malaria and scientists are confident that it will be both safe and effective in humans.

It is believed to be the first time that scientists have made a candidate malaria vaccine based on a blood protein that confers natural resistance to young children. The breakthrough could lead to the first clinical trials of the prototype vaccine within two years, the researchers said.

Malaria kills about 600,000 people each year, most of them young children under the age of five living in sub-Saharan Africa and South East Asia. There are more than 200 million cases a year worldwide and many children who survive infection can still be left with health problems in later life.

Scientists discovered the blood antibodies that confer natural resistance to malaria during a survey of about 785 children in Tanzania. About six per cent of the children possessed antibodies to a malaria protein that is vital for the parasite to complete its lifecycle within the human body.

Although the new candidate vaccine, known as PfSEA-1, has only been tested on mice, the scientists behind the research are excited about its potential in terms of protecting vulnerable children against the most dangerous forms of severe malaria.

The new PfSEA-1 vaccine works by trapping malaria parasites inside infected red blood cells so that they cannot emerge to infect other red blood cells and so complete their complicated life cycle, said Jonathan Kurtis at Rhode Island Hospital in the US.

“It turns out that antibodies to this protein prevent the schizont [a stage in the malaria lifecycle] from getting out of the red cell. We trap the parasite inside the red cell,” Dr Kurtis said.


“Most vaccine candidates for malaria have worked by trying to prevent parasites from entering red blood cells; we’ve taken a different approach. We’re sort of trapping the parasite in the burning house,” he said.

“We have found a way to block it from leaving the cell once it has entered. If it’s trapped in the red blood cells, it can’t go anywhere. It can’t do any further damage,” he added.

About 100 candidate malaria vaccines have been developed over the past 30 years but only one has made it to the final, phase-three stage of clinical trials. However, this vaccine, known as "RTS,S" and made by GlaxoSmithKline, confers less than 50 per cent protection – which many experts believe is better than none.

“Malaria is the single greatest killer of children on the planet. It kills one child every 15 seconds. It’s an unbelievable culling machine of sub-Sarharan Africa and South-East Asia. We need desperately a vaccine against malaria,” Dr Kurtis said.

“It’s unlikely that anything that is immediately on the horizon is going to be actually sufficient efficacious. So our next destination is an active vaccination trial in monkeys, followed by phase-one trials in humans. We’d like to roll this out as quickly as we can,” he said.

The study, published in the journal Science, showed that the PfSEA-1 vaccine can protect laboratory mice from the most severe strains of rodent malaria. The researchers also found that the children with PfSEA-1 antibodies naturally in their blood did not succumb to severe malaria, he added.

“The shocking result was that children who had detectable antibodies to this antigen never got severe malaria – zero cases,” Dr Kurtis said.

Some candidate vaccines have been shown to work well in animals such as mice and monkeys, but they fail to work in humans. This candidate vaccine comes from a natural protein that has been shown to confer high levels of resistance in children and so it should work in humans, he said.

“What really distinguishes this work is that we began with human beings and we can overcome the problem that says we’ve got a great vaccine, I can protect mice but it does not translate at all to human beings,” Dr Kurtis said.

Professor Mike Blackman, a malaria researcher at the National Institute for Medical Research in north London said: “The study is quite an important step forward and potentially raises the prospect of this becoming a vaccine candidate and combining it with other vaccine candidates… but they still have a long way to go.”

In 2011, scientists from the Wellcome Trust Sanger Institute in Cambridge identified the critical protein on the surface of red blood cells that allowed the malaria parasite to gain entry to the cell. The researchers said this protein, known as basigin, could also be used as a target for future prototype vaccines.

Combining two or more vaccines that target different stages of the malaria’s complicated lifecycle are likely to be more effective than just one vaccine, Dr Kurtis said. “We can approach the parasite from all angles,” he said.

Life and Style
food + drinkFrom Mediterranean Tomato Tart to Raw Caramel Peanut Pie
Boys to men: there’s nothing wrong with traditional ‘manly’ things, until masculinity is used to exclude people
indybest13 best grooming essentials
Arts and Entertainment
Armstrong, left, and Bain's writing credits include Peep Show, Fresh Meat, and The Old Guys
TVThe pair have presented their view of 21st-century foibles in shows such as Peep Show and Fresh Meat
ebooksAn unforgettable anthology of contemporary reportage
travelPurrrfect jet comes to Europe
Arts and Entertainment
Benedict Cumberbatch attends the London premiere of his new film The Imitation Game
people He's not as smart as his characters
Life and Style
healthMovember isn't about a moustache trend, it saves lives
Arts and Entertainment
Hand out press photograph/film still from the movie Mad Max Fury Road (Downloaded from the Warner Bro's media site/Jasin Boland/© 2014 Warner Bros. Entertainment Inc.)
films'You have to try everything and it’s all a process of elimination, but ultimately you find your path'
Arts and Entertainment
Keys to success: Andrew and Julian Lloyd Webber
arts + entsMrs Bach had too many kids to write the great man's music, says Julian Lloyd Webber
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Mobile Developer (.NET / C# / Jason / Jquery / SOA)

£40000 - £65000 per annum + bonus + benefits + OT: Ampersand Consulting LLP: M...

Humanities Teacher - Greater Manchester

£22800 - £33600 per annum: Randstad Education Manchester Secondary: The JobAt ...

Design Technology Teacher

£22800 - £33600 per annum: Randstad Education Manchester Secondary: Calling al...

Foundation Teacher

£100 - £125 per day: Randstad Education Chelmsford: EYFS Teachers - East Essex...

Day In a Page

Bryan Adams' heartstopping images of wounded British soldiers to go on show at Somerset House

Bryan Adams' images of wounded soldiers

Taken over the course of four years, Adams' portraits are an astonishing document of the aftermath of war
The drugs revolution starts now as MPs agree its high time for change

The drugs revolution starts now as MPs agree its high time for change

Commons debate highlights growing cross-party consensus on softening UK drugs legislation, unchanged for 43 years
The camera is turned on tabloid editors in Richard Peppiatt's 'One Rogue Reporter'

Gotcha! The camera is turned on tabloid editors

Hugh Grant says Richard Peppiatt's 'One Rogue Reporter' documentary will highlight issues raised by Leveson
Fall of the Berlin Wall: It was thanks to Mikhail Gorbachev that this symbol of division fell

Fall of the Berlin Wall

It was thanks to Gorbachev that this symbol of division fell
Halloween 2014: What makes Ouija boards, demon dolls, and evil clowns so frightening?

What makes ouija boards and demon dolls scary?

Ouija boards, demon dolls, evil children and clowns are all classic tropes of horror, and this year’s Halloween releases feature them all. What makes them so frightening, decade after decade?
A safari in modern Britain: Rose Rouse reveals how her four-year tour of Harlesden taught her as much about the UK as it did about NW10

Rose Rouse's safari in modern Britain

Rouse decided to walk and talk with as many different people as possible in her neighbourhood of Harlesden and her experiences have been published in a new book
Welcome to my world of no smell and odd tastes: How a bike accident left one woman living with unwanted food mash-ups

'My world of no smell and odd tastes'

A head injury from a bicycle accident had the surprising effect of robbing Nell Frizzell of two of her senses

Matt Parker is proud of his square roots

The "stand-up mathematician" is using comedy nights to preach maths to big audiences
Paul Scholes column: Beating Manchester City is vital part of life at Manchester United. This is first major test for Luke Shaw, Angel Di Maria and Radamel Falcao – it’s not a game to lose

Paul Scholes column

Beating City is vital part of life at United. This is first major test for Shaw, Di Maria and Falcao – it’s not a game to lose
Frank Warren: Call me an old git, but I just can't see that there's a place for women’s boxing

Frank Warren column

Call me an old git, but I just can't see that there's a place for women’s boxing
Adrian Heath interview: Former Everton striker prepares his Orlando City side for the MLS - and having Kaka in the dressing room

Adrian Heath's American dream...

Former Everton striker prepares his Orlando City side for the MLS - and having Kaka in the dressing room
Simon Hart: Manchester City will rise again but they need to change their attitude

Manchester City will rise again but they need to change their attitude

Manuel Pellegrini’s side are too good to fail and derby allows them to start again, says Simon Hart
Isis in Syria: A general reveals the lack of communication with the US - and his country's awkward relationship with their allies-by-default

A Syrian general speaks

A senior officer of Bashar al-Assad’s regime talks to Robert Fisk about his army’s brutal struggle with Isis, in a dirty war whose challenges include widespread atrocities